Antimicrobial Stewardship (AMS), Volume Two includes the experience of ESGAP workshops and courses on antibiotic stewardship since 2012. It combines clinical and laboratory information about AMS, with a focus on human medicine.
The ESCMID study group on antibiotic policies (ESGAP) is one of the most productive groups in the field, organizing courses and workshops. This book is an ideal tool for the participants of these workshops.
With short chapters (around 1500 words) written on different topics, the authors insisted on the following points: A ‘hands on’, practical approach, tips to increase success, a description of the most common mistakes, a global picture (out- and inpatient settings, all countries) and a short list of 10-20 landmark references.
1. Introduction by Murat Akova - p. xvii 2. Introduction by Jesús Rodríguez-Baño - p. xix 3. Introduction by Evelina Tacconelli - p. xix 4. Preface - p. xxii 5. Acknowledgments - p. xxv 6. Section A: The Global Picture of Antimicrobial Use and Resistance - p. xxv 7. Chapter 1: The Global Crisis of Antimicrobial Resistance - p. xxv 8. Chapter 2: Antimicrobial Stewardship: Efficacy and Implementation of Strategies to Address Antimicrobial Overuse and Resistance - p. 12 9. Chapter 3: Quality Indicators and Quantity Metrics of Antibiotic Use - p. 28 10. Section B: AMS Strategies - p. 37 11. Chapter 4: Improving Antimicrobial Prescribing: Input from Behavioral Strategies and Quality Improvement Methods - p. 37 12. Chapter 5: Education of Healthcare Professionals on Responsible Antimicrobial Prescribing - p. 53 13. Chapter 6: Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship - p. 68 14. Chapter 7: Pharmacokinetic and Pharmacodynamic Tools to Increase Efficacy - p. 84 15. Chapter 8: The Use of Computerized Decision Support Systems to Support Antimicrobial Stewardship Programs - p. 98 16. Chapter 9: The Role of Microbiology Laboratory in Promoting Antimicrobial Stewardship - p. 114 17. Chapter 10: The Role of Pharmacists - p. 128 18. Chapter 11: The Roles of Nurses in Antimicrobial Stewardship - p. 137 19. Chapter 12: Antifungal Stewardship - p. 145 20. Section C: AMS in Specific Clinical Settings - p. 163 21. Chapter 13: Optimising Prescribing for Acute Respiratory Tract Infections as an Example for Antimicrobial Stewardship in Primary Care - p. 163 22. Chapter 14: Antimicrobial Stewardship: What to Tell the Patients and the General Public - p. 174 23. Chapter 15: Antimicrobial Stewardship in Long-Term Care Facilities - p. 184 24. Chapter 16: Antimicrobial Stewardship in ICU - p. 192 25. Chapter 17: Antimicrobial Stewardship in Hematology Patients - p. 203 26. Chapter 18: AMS in an Era of Multidrug-Resistant Bacteria - p. 217 27. Section D: AMS Experiences Around the World - p. 231 28. Chapter 19.1: AMS Initiatives and Policies: The International Picture - p. 231 29. Chapter 19.2: Missions and Objectives of EUCIC and ESGAP - p. 237 30. Chapter 19.3: Antimicrobial Stewardship in Latin America - p. 241 31. Chapter 19.4: Antimicrobial Stewardship in Australia - p. 246 32. Chapter 19.5: Antimicrobial Stewardship in Austria - p. 249 33. Chapter 19.6: Antimicrobial Stewardship in Belgium - p. 253 34. Chapter 19.7: Antimicrobial Stewardship in Bulgaria - p. 257 35. Chapter 19.8: Antimicrobial Stewardship in Croatia - p. 261 36. Chapter 19.9: Antimicrobial Stewardship in England - p. 265 37. Chapter 19.10: Antimicrobial Stewardship in France - p. 270 38. Chapter 19.11: Antimicrobial Stewardship in Germany - p. 273 39. Chapter 19.12: Antimicrobial Stewardship in Greece - p. 279 40. Chapter 19.13: Antimicrobial Stewardship in India - p. 283 41. Chapter 19.14: Antimicrobial Stewardship in Israel - p. 287 42. Chapter 19.15: Antimicrobial Stewardship in Italy - p. 291 43. Chapter 19.16: Antimicrobial Stewardship in Japan - p. 295 44. Chapter 19.17: Antibiotic Stewardship in the Netherlands - p. 298 45. Chapter 19.18: Antimicrobial Stewardship in Scotland - p. 300 46. Chapter 19.19: Antimicrobial Stewardship in Slovenia - p. 303 47. Chapter 19.20: Antimicrobial Stewardship in South Africa - p. 307 48. Chapter 19.21: Antimicrobial Stewardship in Argentina - p. 311 49. Chapter 19.22: Antimicrobial Stewardship in Spain - p. 315 50. Chapter 19.23: Antibiotic Stewardship in Sweden - p. 319 51. Chapter 19.24: Antimicrobial Stewardship in Switzerland - p. 327 52. Chapter 19.25: Antimicrobial Stewardship in Turkey - p. 330 53. Chapter 19.26: Antimicrobial Stewardship in the United States - p. 333 54. Section E: Research and Perspectives - p. 337 55. Chapter 20: Methodological Challenges in Evaluating Antimicrobial Stewardship Programs: “Through Measuring to Knowledge” - p. 337 56. Index - p. 361 57. List of Abbreviations - p. 363
Antimicrobial Stewardship (AMS), Volume Two includes the experience of ESGAP workshops and courses on antibiotic stewardship since 2012. It combines clinical and laboratory information about AMS, with a focus on human medicine.
The ESCMID study group on antibiotic policies (ESGAP) is one of the most productive groups in the field, organizing courses and workshops. This book is an ideal tool for the participants of these workshops.
With short chapters (around 1500 words) written on different topics, the authors insisted on the following points: A ‘hands on’, practical approach, tips to increase success, a description of the most common mistakes, a global picture (out- and inpatient settings, all countries) and a short list of 10-20 landmark references.
1. Introduction by Murat Akova - p. xvii 2. Introduction by Jesús Rodríguez-Baño - p. xix 3. Introduction by Evelina Tacconelli - p. xix 4. Preface - p. xxii 5. Acknowledgments - p. xxv 6. Section A: The Global Picture of Antimicrobial Use and Resistance - p. xxv 7. Chapter 1: The Global Crisis of Antimicrobial Resistance - p. xxv 8. Chapter 2: Antimicrobial Stewardship: Efficacy and Implementation of Strategies to Address Antimicrobial Overuse and Resistance - p. 12 9. Chapter 3: Quality Indicators and Quantity Metrics of Antibiotic Use - p. 28 10. Section B: AMS Strategies - p. 37 11. Chapter 4: Improving Antimicrobial Prescribing: Input from Behavioral Strategies and Quality Improvement Methods - p. 37 12. Chapter 5: Education of Healthcare Professionals on Responsible Antimicrobial Prescribing - p. 53 13. Chapter 6: Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship - p. 68 14. Chapter 7: Pharmacokinetic and Pharmacodynamic Tools to Increase Efficacy - p. 84 15. Chapter 8: The Use of Computerized Decision Support Systems to Support Antimicrobial Stewardship Programs - p. 98 16. Chapter 9: The Role of Microbiology Laboratory in Promoting Antimicrobial Stewardship - p. 114 17. Chapter 10: The Role of Pharmacists - p. 128 18. Chapter 11: The Roles of Nurses in Antimicrobial Stewardship - p. 137 19. Chapter 12: Antifungal Stewardship - p. 145 20. Section C: AMS in Specific Clinical Settings - p. 163 21. Chapter 13: Optimising Prescribing for Acute Respiratory Tract Infections as an Example for Antimicrobial Stewardship in Primary Care - p. 163 22. Chapter 14: Antimicrobial Stewardship: What to Tell the Patients and the General Public - p. 174 23. Chapter 15: Antimicrobial Stewardship in Long-Term Care Facilities - p. 184 24. Chapter 16: Antimicrobial Stewardship in ICU - p. 192 25. Chapter 17: Antimicrobial Stewardship in Hematology Patients - p. 203 26. Chapter 18: AMS in an Era of Multidrug-Resistant Bacteria - p. 217 27. Section D: AMS Experiences Around the World - p. 231 28. Chapter 19.1: AMS Initiatives and Policies: The International Picture - p. 231 29. Chapter 19.2: Missions and Objectives of EUCIC and ESGAP - p. 237 30. Chapter 19.3: Antimicrobial Stewardship in Latin America - p. 241 31. Chapter 19.4: Antimicrobial Stewardship in Australia - p. 246 32. Chapter 19.5: Antimicrobial Stewardship in Austria - p. 249 33. Chapter 19.6: Antimicrobial Stewardship in Belgium - p. 253 34. Chapter 19.7: Antimicrobial Stewardship in Bulgaria - p. 257 35. Chapter 19.8: Antimicrobial Stewardship in Croatia - p. 261 36. Chapter 19.9: Antimicrobial Stewardship in England - p. 265 37. Chapter 19.10: Antimicrobial Stewardship in France - p. 270 38. Chapter 19.11: Antimicrobial Stewardship in Germany - p. 273 39. Chapter 19.12: Antimicrobial Stewardship in Greece - p. 279 40. Chapter 19.13: Antimicrobial Stewardship in India - p. 283 41. Chapter 19.14: Antimicrobial Stewardship in Israel - p. 287 42. Chapter 19.15: Antimicrobial Stewardship in Italy - p. 291 43. Chapter 19.16: Antimicrobial Stewardship in Japan - p. 295 44. Chapter 19.17: Antibiotic Stewardship in the Netherlands - p. 298 45. Chapter 19.18: Antimicrobial Stewardship in Scotland - p. 300 46. Chapter 19.19: Antimicrobial Stewardship in Slovenia - p. 303 47. Chapter 19.20: Antimicrobial Stewardship in South Africa - p. 307 48. Chapter 19.21: Antimicrobial Stewardship in Argentina - p. 311 49. Chapter 19.22: Antimicrobial Stewardship in Spain - p. 315 50. Chapter 19.23: Antibiotic Stewardship in Sweden - p. 319 51. Chapter 19.24: Antimicrobial Stewardship in Switzerland - p. 327 52. Chapter 19.25: Antimicrobial Stewardship in Turkey - p. 330 53. Chapter 19.26: Antimicrobial Stewardship in the United States - p. 333 54. Section E: Research and Perspectives - p. 337 55. Chapter 20: Methodological Challenges in Evaluating Antimicrobial Stewardship Programs: “Through Measuring to Knowledge” - p. 337 56. Index - p. 361 57. List of Abbreviations - p. 363
